AutoPap system performance in screening for low prevalence and small cell abnormalities

Area of Science:

• Cytopathology
• Medical Diagnostics
• Biomedical Engineering

Background:

• The AutoPap System is an automated device for cervical cancer screening.
• Accurate evaluation of cytological slides is crucial for early cancer detection.
• The evaluation score's performance in challenging cases, such as low abnormal cell prevalence, needs thorough assessment.

Purpose of the Study:

• To evaluate the design principles of the AutoPap System's evaluation score.
• To assess the diagnostic utility of the evaluation score on slides with low prevalence of abnormal cells and small cell abnormalities.

Main Methods:

• Analysis of data from two clinical studies (prospective intended-use and sensitivity studies) involving over 14,000 slides.
• Evaluation of a training set of 4,174 slides from 10 laboratories.
• Comparison of detection capabilities and sensitivities across slides with varying abnormal cell prevalence and sizes.

Main Results:

• The AutoPap evaluation score demonstrated robust design with consistent detection capabilities for both low and high prevalence of abnormal cells.
• No significant performance difference was observed between small cell abnormalities and normal-sized abnormal cells in comparison groups (carcinoma in situ, invasive squamous carcinoma).
• Evaluation scores showed a strong correlation with the diagnostic severity of the evaluated slides.

Conclusions:

• The AutoPap System evaluation score is a reliable diagnostic tool, effective even with subtle cytological abnormalities.
• The system's design ensures consistent performance across diverse slide characteristics, supporting its clinical utility.
• The evaluation score accurately reflects the severity of abnormalities, aiding in clinical decision-making for cervical cancer screening.